Astrivax Therapeutics is a startup based in the Netherlands, most recent round Series A, 1 tracked investor.
Astrivax Therapeutics is a startup founded in 2022 based in the Netherlands. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Astrivax Therapeutics is a clinical stage biopharmaceutical company focused on developing DNA-based immunotherapies through a novel technology platform. The company aims to address challenging diseases, primarily focusing on treating Hepatitis B, Human Papilloma virus, and other emerging viral infectious diseases using its patented plasmid-based Launch-iT technology, which enables the rapid development of immunotherapies and vaccines.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.